N-[(1S)-1-[[[(4S,7R)-Hexahydro-7-methyl-3-oxo-1-(2-pyridinylsulfonyl)-1H-azepin-4-yl]amino]carbonyl]-3-methylbutyl]-2-benzofurancarb oxamide
CAS: 362505-84-8
Ref. 3D-FH158484
Tamanho indefinido | Descontinuado |
Informação sobre produto
- Relacatib
- Gsk-462795
- Sb-462795
N-[(1S)-1-[[[(4S,7R)-Hexahydro-7-methyl-3-oxo-1-(2-pyridinylsulfonyl)-1H-azepin-4-yl]amino]carbonyl]-3-methylbutyl]-2-benzofurancarb oxamide is a drug that is used to treat bone cancer and cancer. It has been shown to have long term efficacy on the reduction of tumor size and the prevention of recurrence. The diagnostic properties of this drug are due to its ability to bind to collagen in the tumor tissue. The pharmacokinetic properties of this drug include a rapid absorption rate, low volume of distribution, high clearance rate, and a long half life. N-[(1S)-1-[[[(4S,7R)-Hexahydro-7-methyl-3-oxo-1-(2-p